All In MedTech

Device Trial Radar · NCT00642876

PRESTIGE® Cervical Disc Study

Investigation of the PRESTIGE® Cervical Disc Device at a Single Level for Symptomatic Cervical Disc Disease

Last checked: Nov 20, 2026Latest source record: May 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 541 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

541

Actual

Start

Oct 2002

Primary completion

Jul 2006

Study completion May 2013

Sponsor

Lead sponsor
Medtronic Spinal and BiologicsPublic (MDT)
Sponsor type
Industry
First posted
Mar 25, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a PMA application for the ACD.

Conditions

  • Degenerative Cervical Disc Disease

Interventions

  • Allograft Fusion and ATLANTIS™ Cervical Plate SystemDevice

    The patients that received the control treatment underwent a single level anterior cervical fusion procedure involving allograft bone and the ATLANTIS™ Cervical Plate System.

  • PRESTIGE® Cervical DiscDevice

    The PRESTIGE® Cervical Disc is a stainless steel device that was inserted into the intervertebral disc space. The device is composed of two metal plates that interface via a ball and socket mechanism permitting segmental spinal motion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary endpoint is overall success, which consists of NDI score, neuro status success, with/without FSU disc ht success, no serious AE classified as "implant/surgical procedure associated", and no secondary surgical procedure classified as failureTime frame: 24 months

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • North Alabama Neurological

    Huntsville, Alabama

  • Montgomery Neurosurgical

    Montgomery, Alabama

  • University of California, Davis

    Sacramento, California

28 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.